Evidence map›Paper›PMID 40852283›Full record

ArticleACS omega2025

Probiotic

Mirna Maciel d'Auriol Souza, Viviani Mendes de Almeida, Clênio Silva Cruz, Victor de Melo Rocha, Paola Caroline Lacerda Leocárdio, Sumaia Araújo Pires, Maysa do Vale Oliveira, Tainá Brumate, Maria José Nunes de Paiva, Jacqueline Isaura Alvarez-Leite and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Mirna Maciel d'Auriol SouzaLaboratório de Análises Toxicológicas (LATO), Faculdade de Farmácia, Universidade Federal de Minas Gerais institution, Belo Horizonte 31270-901, Brazil.ORCID https://orcid.org/0009-0004-2771-5919
Viviani Mendes de AlmeidaLaboratório de Imunomodulação (LMI), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Clênio Silva CruzLaboratório de Imunomodulação (LMI), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Victor de Melo RochaLaboratório de Imunomodulação (LMI), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.ORCID https://orcid.org/0000-0002-0042-3164
Paola Caroline Lacerda LeocárdioLaboratório de Lipídeos, Aterosclerose e Bioquímica Nutricional (LABIN), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Sumaia Araújo PiresLaboratório de Análises Toxicológicas (LATO), Faculdade de Farmácia, Universidade Federal de Minas Gerais institution, Belo Horizonte 31270-901, Brazil.ORCID https://orcid.org/0000-0001-7611-7545
Maysa do Vale OliveiraDepartamento de Ciências da Saúde (DCS), Universidade Federal do Espírito Santo, Vitória, São Mateus 29945500, Brazil.
Tainá BrumateLaboratório de Análises Toxicológicas (LATO), Faculdade de Farmácia, Universidade Federal de Minas Gerais institution, Belo Horizonte 31270-901, Brazil.
Maria José Nunes de PaivaLaboratório de Análises Toxicológicas (LATO), Faculdade de Farmácia, Universidade Federal de Minas Gerais institution, Belo Horizonte 31270-901, Brazil.
Jacqueline Isaura Alvarez-LeiteLaboratório de Lipídeos, Aterosclerose e Bioquímica Nutricional (LABIN), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Geovanni Dantas CassaliLaboratório de Patologia Comparada (LPC), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Flaviano Santos MartinsLaboratório de Agentes Bioterapêuticos (LABio), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Angélica Thomaz VieiraLaboratório de Imunomodulação (LMI), Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Belo Horizonte 31270-901, Brazil.
Leiliane Coelho AndréLaboratório de Análises Toxicológicas (LATO), Faculdade de Farmácia, Universidade Federal de Minas Gerais institution, Belo Horizonte 31270-901, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Environmental exposure to low levels of pesticide mixtures through food and domestic settings raises significant public health concerns due to their potential link to metabolic diseases, including obesity, type 2 diabetes, and cancer. As the intestinal microbiota and gastrointestinal tract serve as primary contact points for these contaminants, potentially eliminating residues or suffering direct damage leading to dysbiosis, probiotic interventions have emerged as promising therapeutic strategies for metabolic disorders. This study aimed to evaluate, in mice, the consequences of subchronic exposure to low doses of a mixture of three pesticides: glyphosate (15 mg/kg body weight/day), imidacloprid (5 mg/kg body weight/day), and tebuconazole (4 mg/kg body weight/day). Mice were exposed for 6 weeks. The probiotic

Identifiers

PMID40852283
PMCPMC12368810

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.